Vela Diagnostics
Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies
Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies.
Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test
The second EUA for a test that targets the ORF1a and N genes is for an automated version of a manual test that had been granted EUA in August.
Vela Diagnostics, Capstone Healthcare Get FDA Emergency Use Authorization for Coronavirus Tests
The Vela and Capstone tests are both PCR-based and designed to detect their viral RNA targets in nasopharyngeal and oropharyngeal swab specimens.
Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark
Vela Diagnostics said that the RT-PCR-based test has also received provisional authorization from the Health Sciences Authority in Singapore.
Vela Diagnostics, JN Medsys Get CE-IVD Marks for Coronavirus Tests
Vela anticipates CE-IVD marking for an automated version of its test, and JN Medsys has received authorization for its test in Singapore and the Philippines.
Jul 23, 2018
Jun 25, 2018
Vela Diagnostics Buys Great Basin Scientific
Aug 18, 2017
Great Basin in Default of Senior Notes for $18.3M
Jun 22, 2017
Great Basin Closes $2.1M Offering
May 23, 2017
Great Basin Plans to Raise $3.5M
May 22, 2017
Great Basin Reports 14 Percent Revenue Growth in Q1
May 16, 2017
Great Basin Whooping Cough Test Gets CE Marking
Apr 12, 2017
Great Basin Gets CE Mark for Stool Pathogens Panel
Apr 3, 2017
Great Basin Whooping Cough MDx Clears FDA
Mar 22, 2017
Great Basin Q4 Revenues Rise 39 Percent
Feb 14, 2017